Pulmonx Corp (LUNG): Long-Term Debt

Annual figures by period end, from SEC filings.

$37.09M
As of 2025-12-31
$37.53M
As of 2026-06-30
+28.9%
3-year compound annual growth
+16.4%
5-year compound annual growth
$37.24M2020-12-31: $17.37M2021-12-31: $17.41M2022-12-31: $17.32M2023-12-31: $37.24M2024-12-31: $37.18M2025-12-31: $37.09M$37.09M
2020-12-31 Long-Term Debt (USD) 2025-12-31
Period endedLong-Term DebtChange YoYSource filing
2025-12-31$37.09M-0.2%2026-03-10, Balance as of period end
2024-12-31$37.18M-0.2%2025-02-25, Balance as of period end
2023-12-31$37.24M+115.0%2024-02-27, Balance as of period end
2022-12-31$17.32M-0.5%2023-03-01, Balance as of period end
2021-12-31$17.41M+0.3%2022-03-01, Balance as of period end
2020-12-31$17.37Mn/a2021-03-15, Balance as of period end

Long-Term Debt at similar companies

Companies with the same SEC industry code (Surgical & Medical Instruments & Apparatus), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

CompanyYear endedLong-Term DebtChange YoY
Pulmonx Corp (LUNG)2025-12-31$37.09M-0.2%
Delcath Systems, Inc. (DCTH)2024-12-31$0-100.0%
TELA Bio, Inc. (TELA)2024-12-31$41.12M+1.5%
PRO DEX Inc (PDEX)2026-06-30$17.51M+13.5%
Sight Sciences, Inc. (SGHT)2025-12-31$42.38M+5.9%
Xtant Medical Holdings, Inc. (XTNT)2025-12-31$11.03M-50.0%
InfuSystem Holdings, Inc (INFU)2025-12-31$19.62M-17.8%
Neuronetics, Inc. (STIM)2025-12-31$65.81M+19.3%
Apyx Medical Corp (APYX)2025-12-31$37.50M0.0%

Compare LUNG, DCTH, TELA, PDEX side by side · Screen every company in Surgical & Medical Instruments & Apparatus ↗